Literature DB >> 16926080

Identification of a new impurity in lisinopril.

Vikas Shinde1, Anurag Trivedi, P R Upadhayay, N L Gupta, D G Kanase, Rajeev Chikate.   

Abstract

LC-UV scan of lisinopril revealed the presence of an unknown impurity (approximately 0.14%) at a relative retention time of 3.26 employing phosphate buffer-acetonitrile as binary gradient system while LC-MS analysis with binary gradient system comprising of a ammonia-ammonium acetate buffer (pH 5.0) and acetonitrile indicated it to be C31H41N3O7. The impurity was isolated by preparative HPLC utilizing a linear gradient of water and acetonitrile. The structural analysis of the isolated product by 1H, 13C NMR, mass spectroscopy and FT-IR revealed it to be a 4-phenyl butanoic acid derivative (CL) of lisinopril.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16926080     DOI: 10.1016/j.jpba.2006.06.046

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Combination of anti-hypertensive drugs: a molecular dynamics simulation study.

Authors:  Abbas Yousefpour; Hamid Modarress; Fatemeh Goharpey; Sepideh Amjad-Iranagh
Journal:  J Mol Model       Date:  2017-04-10       Impact factor: 1.810

2.  Characterization of impurities in the bulk drug lisinopril by liquid chromatography/ion trap spectrometry.

Authors:  Pei-xi Zhu; Dan-hua Wang; Cui-rong Sun; Zhi-quan Shen
Journal:  J Zhejiang Univ Sci B       Date:  2008-05       Impact factor: 3.066

3.  Synthesis and Characterization of Compounds Related to Lisinopril.

Authors:  Ambati V Raghava Reddy; Srinivas Garaga; Chandiran Takshinamoorthy; Andra Naidu; Ramesh Dandala
Journal:  Sci Pharm       Date:  2015-10-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.